(Q34107982)

31 July 2017

1 reference

title

Advances in cancer pain management. (English)

1 reference

31 July 2017

0 references

1 reference

McDonnell FJ

1

1 reference

31 July 2017

Sloan JW

series ordinal

2

1 reference

31 July 2017

Hamann SR

series ordinal

3

1 reference

31 July 2017

publication date

1 July 2000

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

351-357

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-000-0029-5

31 July 2017

exact match

0 references

cites work

High-dose intravenous pamidronate for metastatic bone pain

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-000-0029-5

Spinal coadministration of ketamine reduces the development of tolerance to visceral as well as somatic antinociception during spinal morphine infusion.

21 January 2018

1 reference

12 December 2020

Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus

1 reference

12 December 2020

Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation

1 reference

12 December 2020

Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception

1 reference

12 December 2020

Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats☆

1 reference

12 December 2020

The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn

1 reference

12 December 2020

The opioid-sparing effects of intravenous ketorolac as an adjuvant analgesic in cancer pain: application in bone metastases and the opioid bowel syndrome

1 reference

12 December 2020

Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.

1 reference

12 December 2020

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

1 reference

12 December 2020

Cost utility analysis of prophylactic pamidronate for the prevention of skeletal related events in patients with advanced breast cancer

1 reference

12 December 2020

Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief

1 reference

12 December 2020

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites

1 reference

12 December 2020

Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain

1 reference

12 December 2020

Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment

1 reference

12 December 2020

The treatment of cancer pain

1 reference

12 December 2020

Role of pamidronate disodium in the treatment of metastatic bone disease

1 reference

12 December 2020

The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials

1 reference

12 December 2020

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients

1 reference

12 December 2020

Opioid rotation: does it have a role?

1 reference

12 December 2020

Mechanism of action of antiinflammatory drugs

1 reference

12 December 2020

Pamidronate treatment in patients with malignant osteolytic bone disease and pain: a prospective randomized double-blind trial

1 reference

12 December 2020

Pharmacokinetics and analgesic effect of ketamine in man.

1 reference

12 December 2020

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

1 reference

12 December 2020

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

1 reference

12 December 2020

Bisphosphonates for metastatic bone pain

1 reference

12 December 2020

Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study

1 reference

12 December 2020

Cancer pain management

1 reference

12 December 2020

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development

1 reference

12 December 2020

The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans

1 reference

12 December 2020

The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future

1 reference

12 December 2020

Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain

1 reference

12 December 2020

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord

1 reference

12 December 2020

Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial

1 reference

12 December 2020

Pharmacology and mechanisms of opioid analgesic activity

1 reference

12 December 2020

The need for ketamine.

1 reference

12 December 2020

Different doses of pamidronate in patients with painful osteolytic bone metastases.

1 reference

12 December 2020

Successful use of methadone in nociceptive cancer pain unresponsive to morphine

1 reference

12 December 2020

Cancer pain management

1 reference

12 December 2020

d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia

1 reference

12 December 2020

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

1 reference

12 December 2020

The cyclooxygenase-2 inhibitors: safety and effectiveness

1 reference

12 December 2020

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

12 December 2020

Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine.

1 reference

12 December 2020

Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.

1 reference

12 December 2020

Morphine in cancer pain: modes of administration. Expert Working Group of the European Association for Palliative Care

1 reference

12 December 2020

Clinical experience with oral ketamine

1 reference

12 December 2020

Malignant bone pain: pathophysiology and treatment

1 reference

12 December 2020

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

12 December 2020

Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain

1 reference

12 December 2020

Analgesic effects of nonsteroidal anti-inflammatory drugs in cancer pain due to somatic or visceral mechanisms.

1 reference

12 December 2020

The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states

1 reference

12 December 2020

GM1 ganglioside-induced modulation of opioid receptor-mediated functions

1 reference

12 December 2020

Mechanism of action of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Opioid hyperexcitability: the application of alternate opioid therapy

1 reference

12 December 2020

Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain

1 reference

12 December 2020

Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability

1 reference

12 December 2020

10.1007/S11912-000-0029-5

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1012594658

0 references

1 reference